Actively hiring
Oncology Therapeutics
Drug Discovery
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$155.5M
2 rounds on record
Latest round
$88.5M
Venture round · Jun 2021 · 5 yr ago
Hiring now
2
open roles
Backers
3
RA Capital Management, DCVC
The money's age
Long since its last round
63 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 12, 2021
New executive Gregory Chow, Executive Officer · SEC Form D
Jun 25, 2021
Raised a round Venture round $88.5M · SEC Form D
Nov 6, 2020
New executive Kevin Webster, Executive Officer · SEC Form D
Apr 18, 2019
Raised a round Venture round $67M · SEC Form D
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2021 | $88.5M | — | SEC Form D |
| Venture round | Apr 2019 | $67M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Frontier Medicines Corp | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Johannes Hermann Ph.D.Executive OfficerSEC Form D
Chris Varma Ph.D.Executive Officer, DirectorSEC Form D
Jim WinklerExecutive OfficerSEC Form D
Kevin WebsterExecutive OfficerSEC Form D
Gregory ChowExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one


backs PLEASE READ THIS AG
Similar startupsby what they do, their industry and backers

Innovating Beyond. We are dedicated to advancing transformative medicines for people living with serious respiratory diseases, leveraging…

Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can…

We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.

A bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common…

Magnet Biomedicine is advancing monovalent molecular glue inhibitors (MGIs) and innovative protein degraders to engage disease drivers.

Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
News
Technologies
Pairing chemoproteomics with machine learning algorithms, Frontier Medicines finds druggable hotspots and ligands within proteins involved in disease
Read more
Report
Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors
April 13, 2026 The post Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors first appeared on Frontier Medicines.
Read more
Report
Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier Platform at AACR Annual Meeting 2026
Read more
Report
Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.
April 1, 2026 The post Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd. first appeared on Frontier Medicines.
Read more
Report
Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier Platform at AACR Annual Meeting 2026
March 17, 2026 The post Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier Platform at AACR Annual Meeting 2026 first appeared on Frontier Medicines.
Read more
Report
Precision-Based
Frontier Medicines' therapeutic priorities focus on developing precision medicines for difficult-to-treat cancers
Read more
Report
Report
Report
Show more news
Tech stack
Technologies named in job postings at Frontiermeds over the last 12 months, by layer, with the share of postings for each.
Technologies in use
17
Postings analysed
5
Stack modernity
63/100
Languages
Python
Frameworks & libraries
DeepSpeed
FSDP
Cloud & platforms
GCP
Sign in to see how your skills match this stack
Sign In
Full Frontiermeds tech stack
17 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$164k
Typical range
$159k – $170k
Open positions
2
2
Jobs
Junior
50%
Senior
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $159k | $159k |
| Senior | 1 | $170k | $170k |
Highest paying role
Sr. Clinical Trial Manager
$170k
Normalized to USD per year
People

Johannes Hermann Ph.D.
Executive Officer

Chris Varma Ph.D.
Executive Officer, Director

Jim Winkler
Executive Officer

Kevin Webster
Executive Officer

Gregory Chow
Executive Officer

Cameron Wheeler
Director

Janwillem Naesens
Director

Othman Laraki
Director

Luke Evnin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
83/100
Scaling fast
Open positions
2
1 opened / 3 closed in 30 days
Median time-to-fill
22 days
faster than 51% of the market
ATS activity
Every ~6 hours
10/16/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
33% ▲
Early Careers
33% ▼
Finance
17% ▲
Sales
17% ▼
Activity Timeline
Added Machine Learning to stack
Sep 2026
Added Tool Use to stack
Sep 2026
Added Multi-Agent Systems to stack
Sep 2026
Added Function Calling to stack
Aug 2026
Added AI Agents to stack
Aug 2026
Added Human-in-the-Loop to stack
Aug 2026
Added FSDP to stack
Aug 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
Boston
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Boston
United States
HQ
451 D Street, Suite 207 Boston, MA 02210
1 open roles 6 posted in 90 days $170k Avg Salary
hires for Early Careers
451 D St., Suite 207, Boston, MA 02210
South San Francisco
United States
Regional office
151 Oyster Point Blvd., 2nd Floor South San Francisco, CA 94080
1 open roles 100% engineering $159k Avg Salary
hires for AI/ML
151 Oyster Point Blvd., 2nd Floor, South San Francisco, CA 94080
Jobs
$100k – $159k per year • Equity • In office • Full-Time • 2+ years exp • Bachelor's Degree • South San Francisco
Python
DeepSpeed
Reinforcement Learning
Multimodal AI
Function Calling
Diffusion Models
AI Agents
Transfer Learning
RAG
Mixture of Experts
Self-Supervised Learning
FSDP
Human-in-the-Loop
Multi-Agent Systems
Tool Use
Machine Learning
Apply

RA Capital Management
DCVC
MPM BioImpact 


